Humasis Co. Ltd.

₩2,175As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:205470Healthcare
Country South Korea
PE (Fwd) •••
TSR 9Y CAGR (0.35%)
Div yield —
ROE (10.97%)
Medical Devices
Beta (5Y) 0.08
PE TTM —
TSR TTM (64.43%)
Mkt cap ₩49.20B
ROIC (16.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,363
8.65%
(50.03%)
Hold 8|7|6|2|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
34.42
35.06
38.16
37.32
32.03%
24.71%
28.18%
20.37%
Revenue₩B
5.651
5.989
5.952
5.949
15.09%
16.09%
8.96%
2.94%
Peers (US$36.27M)
Cap (US$)
PE
43.01M
—
37.68M
0.928x
37.30M
—
36.31M
—
Capital
TTM
5Y
10Y
Leveragex
0.556
0.335
0.340
EBIT/Intx
1.450
0.839
0.688
Own earn%
3.59
13.35
9.05
Sh yield%
31.78
27.53
26.84
Owners
Insiders/Inst%
4.70
55.20
Short interest%
0.80
SBC / revenue%
1.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
18–25
$1 testx
—
Incr. ROIC%
7